Nursing Considerations for Administration and Management of Blinatumomab

Background: Pediatric acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy. Although cure rates exceed 85%, current chemotherapy regimens have high toxicity rates, and the prognosis for patients who relapse remains poor. Immunotherapy has allowed for a reduction in adverse effe...

Ausführliche Beschreibung